Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Heart Test Laboratories (HSCSW)

Heart Test Laboratories Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HSCSW
DateTimeSourceHeadlineSymbolCompany
04/06/202421:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HSCSWHeart Test Laboratories Inc
04/06/202421:15GlobeNewswire Inc.HeartSciences Regains Compliance with Nasdaq Listing RequirementsNASDAQ:HSCSWHeart Test Laboratories Inc
22/05/202421:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HSCSWHeart Test Laboratories Inc
20/05/202414:00GlobeNewswire Inc.HeartSciences Announces Further Internationalization of its AI-ECG Patent PortfolioNASDAQ:HSCSWHeart Test Laboratories Inc
16/05/202417:30Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:HSCSWHeart Test Laboratories Inc
15/05/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HSCSWHeart Test Laboratories Inc
24/04/202414:00GlobeNewswire Inc.HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECGNASDAQ:HSCSWHeart Test Laboratories Inc
02/04/202421:15GlobeNewswire Inc.HeartSciences to Present at the LD Micro Invitational XIV ConferenceNASDAQ:HSCSWHeart Test Laboratories Inc
26/03/202413:00GlobeNewswire Inc.HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative PatientsNASDAQ:HSCSWHeart Test Laboratories Inc
14/03/202420:15GlobeNewswire Inc.HeartSciences Reports Third Quarter Fiscal 2024 Financial ResultsNASDAQ:HSCSWHeart Test Laboratories Inc
12/03/202413:00GlobeNewswire Inc.HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 DiabetesNASDAQ:HSCSWHeart Test Laboratories Inc
06/03/202414:00GlobeNewswire Inc.HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet TechnologyNASDAQ:HSCSWHeart Test Laboratories Inc
26/02/202414:00GlobeNewswire Inc.HeartSciences Adds Key Advisor to its Scientific Advisory BoardNASDAQ:HSCSWHeart Test Laboratories Inc
12/02/202414:00GlobeNewswire Inc.HeartSciences Expands its Scientific Advisory BoardNASDAQ:HSCSWHeart Test Laboratories Inc
01/02/202414:00GlobeNewswire Inc.HeartSciences Appoints New Scientific Advisory Board MemberNASDAQ:HSCSWHeart Test Laboratories Inc
18/01/202413:00GlobeNewswire Inc.HeartSciences Announces Results and Adjournment of Annual Shareholder MeetingNASDAQ:HSCSWHeart Test Laboratories Inc
03/01/202421:15GlobeNewswire Inc.HeartSciences Reminds Stockholders to Vote at the Upcoming Annual Shareholder MeetingNASDAQ:HSCSWHeart Test Laboratories Inc
14/12/202321:15GlobeNewswire Inc.HeartSciences Reports Second Quarter Fiscal 2024 Financial ResultsNASDAQ:HSCSWHeart Test Laboratories Inc
05/12/202313:00GlobeNewswire Inc.HeartSciences Receives FDA Confirmation for 510(k) Clearance PathwayNASDAQ:HSCSWHeart Test Laboratories Inc
20/11/202313:00GlobeNewswire Inc.HeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular AlgorithmsNASDAQ:HSCSWHeart Test Laboratories Inc
13/11/202313:45GlobeNewswire Inc.HeartSciences’ MyoVista® wavECGTM Selected for Heart Screening of Irish Garda National Police OfficersNASDAQ:HSCSWHeart Test Laboratories Inc
19/10/202314:00GlobeNewswire Inc.HeartSciences Issues Investor Update Highlighting Recent Key Achievements and Positive DevelopmentsNASDAQ:HSCSWHeart Test Laboratories Inc
26/09/202313:00GlobeNewswire Inc.HeartSciences Receives Two New Patent Allowances, Expanding its International Patent PortfolioNASDAQ:HSCSWHeart Test Laboratories Inc
25/09/202313:00GlobeNewswire Inc.HeartSciences to Participate in the Maxim Group Virtual Tech Conference Series: Emerging Growth in A.I.NASDAQ:HSCSWHeart Test Laboratories Inc
21/09/202313:00GlobeNewswire Inc.HeartSciences Signs Definitive Agreements with the Icahn School of Medicine at Mount Sinai to Commercialize Artificial Intelligence Cardiovascular AlgorithmsNASDAQ:HSCSWHeart Test Laboratories Inc
14/09/202321:15GlobeNewswire Inc.HeartSciences Reports First Quarter Fiscal 2024 Financial ResultsNASDAQ:HSCSWHeart Test Laboratories Inc
12/09/202321:15GlobeNewswire Inc.HeartSciences to Present at the Gilmartin Group Emerging Growth ShowcaseNASDAQ:HSCSWHeart Test Laboratories Inc
11/09/202321:15GlobeNewswire Inc.HeartSciences Named Electrocardiography Advancement Specialists of the Year 2023 - USA in the Global Health & Pharma Excellence AwardsNASDAQ:HSCSWHeart Test Laboratories Inc
07/09/202314:00GlobeNewswire Inc.HeartSciences Signs Distribution Agreement with MedPhy Technologies, Mumbai, IndiaNASDAQ:HSCSWHeart Test Laboratories Inc
31/08/202314:00GlobeNewswire Inc.HeartSciences Signs Distribution Agreement with FJ Medical, DenmarkNASDAQ:HSCSWHeart Test Laboratories Inc
 Showing the most relevant articles for your search:NASDAQ:HSCSW